Status:
WITHDRAWN
Systemic Absorption of Lidocaine After Hematoma Block
Lead Sponsor:
Washington University School of Medicine
Conditions:
Radius Fracture Distal
Hematoma
Eligibility:
All Genders
5-17 years
Phase:
PHASE4
Brief Summary
This study will measure in children how much numbing medicine, lidocaine, is absorbed into the bloodstream after it is injected into a blood clot (hematoma) around a forearm fracture for pain control ...
Detailed Description
When a subject with an eligible distal forearm fracture is identified, the subject will be approached for enrollment and consent. 50% nitrous oxide/50% oxygen then will be administered to the subject...
Eligibility Criteria
Inclusion
- ASA status class 1 or 2
- Ages 5-17
- Parent/guardian is present
Exclusion
- Open fracture
- Previous attempt at reduction
- Multiple other injuries
- Physeal (growth plate) fractures
- Volar displacement of the distal fracture fragment
- Delayed presentation (\>48 hrs from injury)
- Concern for significant neurovascular injury
- Refracture through a healing fracture
- History of adverse effect from lidocaine or nitrous oxide
- Active psychosis
- Non English speaking parents
- Liver disease
- Cardiac disease
- Abnormal bones such as osteogenesis imperfecta or osteopenia from lack of use
- Developmental abnormalities
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04359017
Start Date
November 1 2020
End Date
December 1 2023
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Louis Children's Hospital
St Louis, Missouri, United States, 63110